Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Bibliografiset tiedot
Päätekijä: Akter, Anika
Muut tekijät: Alam, Marzia
Aineistotyyppi: Opinnäyte
Kieli:English
Julkaistu: Brac University 2022
Aiheet:
TNF-alpha
Rheumatoid arthritis
Biologics
Biosimilars
Adalimumab
ABP-501
Pharmacokinetics
Immunogenicity
Plaque psoriasis
Inflammation
Immunity
Linkit:http://hdl.handle.net/10361/17039

Internet

http://hdl.handle.net/10361/17039

Samankaltaisia teoksia